Science & Research
Alzamend Neuro Launches Phase II Trial for Innovative Lithium-Based Alzheimer's Therapy
Alzamend Neuro has initiated a Phase II clinical trial for AL001, a novel lithium therapy targeting multiple neuropsychiatric conditions, with potential to improve brain drug delivery and reduce side effects.
RNA Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has appointed Dr. Phillip D. Zamore, a leading RNAi researcher, to its Scientific Advisory Board, potentially strengthening the company's oncology research capabilities and RNA therapeutic development strategies.
Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials
Bioadaptives Inc's PawPa division has developed Regen Dog Chews that demonstrate significant potential for improving canine health through natural stem cell stimulation, with clinical trials showing a dramatic increase in circulating stem cells.
RNAi Pioneer Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has added renowned RNA biology expert Dr. Phillip D. Zamore to its Scientific Advisory Board, potentially strengthening the company's RNA-targeted cancer therapy research and development strategy.
RNAi Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics strengthens its scientific leadership by appointing renowned RNA interference expert Dr. Phillip Zamore to its Scientific Advisory Board, potentially boosting the company's cancer therapeutic research capabilities.
NanoViricides Reveals Breakthrough Antiviral Platform at BIO International Convention
NanoViricides will showcase its novel NV-387 broad-spectrum antiviral drug candidate, which demonstrates promising preclinical efficacy against multiple viral infections, potentially revolutionizing viral treatment approaches.
Quantum BioPharma Advances Clinical Trial for MCAS Pain Treatment
Quantum BioPharma has received Australian ethics approval for a Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with Mast Cell Activation Syndrome (MCAS), signaling progress in addressing a challenging medical condition.
Cultural Differences Reveal Unique Sodium Intake Patterns Across Racial Groups
A new study explores how different racial and ethnic groups consume sodium, highlighting unique food sources and salt usage habits. The research provides insights into potential strategies for reducing sodium intake and improving heart health.
FDA Updates COVID-19 Vaccination Strategy, GeoVax Poised to Meet Targeted Needs
The FDA has shifted to a risk-based COVID-19 vaccination approach, prioritizing protection for vulnerable populations. GeoVax's multi-antigen vaccine GEO-CM04S1 appears well-positioned to address these evolving public health requirements.
Miami Surgeon Pioneers Zero-Pain Aesthetic Procedures with Innovative Technique
Dr. Rian Maercks of The Maercks Institute introduces a revolutionary surgical approach using Exparel, enabling aesthetic procedures with minimal pain, no opioids, and rapid recovery, potentially transforming patient experiences in plastic surgery.
American Heart Association Launches Initiative to Improve Clinical Trial Access for Rare Heart Condition
The American Heart Association is addressing healthcare disparities by launching a comprehensive initiative to improve education, outreach, and access to clinical trials for transthyretin amyloid cardiomyopathy (ATTR-CM), focusing on underrepresented populations and emerging gene editing therapies.
CD BioSciences Advances Aging Research with Customizable Mouse Models
CD BioSciences has developed highly customizable mouse models for aging research, offering pharmaceutical and biotech companies precision tools to accelerate drug discovery and understand age-related diseases more effectively.
ESGold Discovers Promising New Exploration Target at Montauban Project
ESGold Corp. has identified a significant geophysical anomaly in the southwest portion of its Montauban Project in Quebec, revealing potential for high-value mineral deposits. The discovery represents an exciting opportunity for future exploration and potential resource expansion.
Beam Therapeutics to Unveil Promising Sickle Cell Disease Treatment Data at European Hematology Congress
Beam Therapeutics will present updated results from its BEACON trial for BEAM-101, an innovative ex vivo cell therapy targeting sickle cell disease, highlighting potential breakthrough treatment approaches at the European Hematology Association 2025 Congress.
Beam Therapeutics to Present Breakthrough Sickle Cell Disease Data at European Hematology Congress
Beam Therapeutics will reveal updated results from its BEACON trial on BEAM-101, an innovative ex vivo cell therapy targeting severe sickle cell disease, highlighting potential advances in genetic medicine treatment strategies.
Soligenix Develops Novel Therapy to Address Antibiotic-Resistant Bacterial Infections
Soligenix's SGX943 represents a potential breakthrough in combating antibiotic-resistant bacteria, offering a novel broad-spectrum therapy that could help address a critical public health challenge.
Creative Biolabs Expands CAR-T Therapy Development with Comprehensive CDMO Services
Creative Biolabs is offering end-to-end solutions for CAR-T therapy development, providing comprehensive services from plasmid design to viral vector manufacturing, potentially accelerating personalized cancer treatment research.
Breakthrough Brain Tumor Test Promises Faster Diagnosis
A new diagnostic test for brain tumors could dramatically reduce the time needed for accurate diagnosis, potentially improving patient outcomes by enabling quicker treatment decisions.
Soligenix's HyBryte Shows Promising Results in Rare Cancer Treatment
Soligenix reports significant progress in treating cutaneous T-cell lymphoma (CTCL) with its experimental therapy HyBryte, demonstrating 75% treatment success after 18 weeks of clinical trials. The breakthrough offers potential hope for patients with this challenging rare skin cancer.
Calidi Biotherapeutics Unveils Promising Cancer Therapy Platform RTNova
Calidi Biotherapeutics has developed RTNova, an innovative gene therapy platform targeting tumors with minimal damage to healthy tissues, potentially revolutionizing cancer treatment approaches.
NanoViricides Highlights Potential Antiviral Solution Amid Changing COVID Booster Recommendations
NanoViricides' President Dr. Anil Diwan comments on the FDA's updated COVID-19 booster policy, emphasizing the need for alternative antiviral treatments and positioning the company's NV-387 drug candidate as a potential solution for respiratory viral infections.
Tonix Pharmaceuticals CEO Highlights Strategic Developments at A.G.P. Healthcare Showcase
Tonix Pharmaceuticals CEO Seth Lederman shared key strategic insights during a fireside chat, emphasizing the company's integrated business model and advanced clinical pipeline, with particular focus on potential treatments for fibromyalgia and potential defense-related medical innovations.
Two Decades of Progress: Heart Failure Care Shows Significant Improvement
A comprehensive analysis of the American Heart Association's Get With The Guidelines® - Heart Failure program reveals substantial advancements in heart failure patient care over 20 years, demonstrating how data-driven quality improvement efforts can dramatically enhance patient survival rates.
NASA Budget Cuts Won't Halt Space Exploration: Solar Technology Poised to Advance
Despite NASA's budget reduction, space exploration continues to evolve with private sector innovation and advanced solar technologies. Ascent Solar Technologies stands ready to play a crucial role in powering future space missions through its lightweight, flexible solar panels.
ProtoSpace Mfg Marks Decade of Support for Mars Rover Innovation Challenge
ProtoSpace Mfg continues its commitment to aerospace innovation by sponsoring the 2025 University Rover Challenge, providing critical manufacturing support to student teams developing advanced Mars rover prototypes. The company's decade-long involvement highlights its dedication to nurturing emerging engineering talent.
Bone Science Launches Advanced Spermidine Supplement Targeting Anti-Aging Market
Bone Science introduces Prime Spermidine, a high-purity plant-derived supplement targeting cellular renewal and longevity. The product leverages cutting-edge research on spermidine's potential to enhance immune function, cognitive health, and overall age-related vitality.
Creative Biolabs Advances Exosome Research with Enhanced Platform Capabilities
Creative Biolabs has upgraded its Extracellular Vesicle platform, offering more precise exosome isolation, characterization, and RNA sequencing techniques that could accelerate disease research and diagnostic capabilities.
Tonix Pharmaceuticals Launches Phase 2 Trial for Acute Stress Reaction Treatment
Tonix Pharmaceuticals has initiated a Department of Defense-backed clinical trial to evaluate TNX-102 SL as a potential treatment for acute stress reaction in motor vehicle trauma survivors, addressing a critical need in mental health care.
Telomir Pharmaceuticals Secures $3M Investment to Advance Age-Reversal Research
Telomir Pharmaceuticals has received a strategic $3 million equity investment from The Bayshore Trust, bolstering its efforts to develop potential breakthrough therapies targeting age-related diseases and longevity.
Aston Bay Holdings Launches 2025 Exploration Program at Storm Copper Project in Nunavut
Aston Bay Holdings is initiating a strategic exploration program at its Storm Copper Project in Nunavut, Canada, targeting new copper discoveries and expanding existing deposits through advanced geophysical techniques and drilling. The program represents a significant step in developing potential high-grade copper resources in the region.